Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Posex Forte is a proprietary Ayurvedic herbo-mineral formulation developed by Charak to manage various bleeding disorders. It acts as a natural haemostyptic (hemostatic) agent, helping to arrest bleeding safely and effectively. The formulation contains a blend of traditional herbo-mineral preparations (bhasmas) and herbal extracts, including Phitsari Shuddha (purified alum), Chandrakala Ras, Kukkutandtwak Bhasma, Lodhra, and Amalaki, which possess astringent and vasoconstrictive properties. Posex Forte is indicated for the management of dysfunctional uterine bleeding, menorrhagia, metrorrhagia, postpartum bleeding, bleeding associated with intrauterine contraceptive device (IUCD) insertion, epistaxis (nosebleeds), hematuria, and bleeding hemorrhoids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Posex Forte.